Cellesce was founded in 2013 and is built on biochemical and bioprocess engineering expertise from the University of Bath and cell and organoid biology expertise from Cardiff University. In December 2017 Cellesce moved into the Medicentre in Cardiff, Wales.
Cellesce is a Biotech company that has developed a new patented bioprocessing technology for the growing and expansion of organoids. Organoids are a 3D cell structures with organ-like characteristics grown from stem cells. The Company is currently commercialising organoid models that are a powerful new enabling technology in drug discovery and genetics research.
Cellesce has initially focused on providing expansion services for colorectal cancer and other organoids. These colorectal cancer organoids reflect the genetic diversity found in the major colorectal cancer sub-types. Full exome sequencing, mutational analysis and pharmacology data are provided for each organoid to demonstrate their relevance to tumour pathology. These can now be made available in commercial quantities required for compound screening in drug discovery or large-scale genetics research, as required. For example, we can provide expansion services for organoids derived from our biobank partners.
*Based on assays performed in 96 or 384 well format
Custom expansion services
Cellesce has not received any reviews.
Cellesce has not received any endorsements.